MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

Xencor Inc (XNCR)

For the quarter ending 2025-06-30, XNCR made $43,608K in revenue. -$30,825K in net income. Net profit margin of -70.69%.

Overview

Revenue
$43,608K
Net Income
-$30,825K
Net Profit Margin
-70.69%
EPS
-$0.41
Unit: Thousand (K) dollars
Revenue Breakdown
    • Morpho Sys Incyte
    • Alexion Pharmaceuticals Inc
    • Vir Biotechnology Inc.
Revenue Breakdown
    • Milestone
    • Royalty

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
2025-06-30
2025-03-31
2024-09-30
2024-06-30
Collaborations, milestones, and royalties43,608 32,732 17,796 23,907
Research and development61,665 58,578 58,226 61,531
General and administrative15,115 17,337 14,767 17,746
Total operating expenses76,780 75,915 72,993 79,277
Operating loss-33,172 -43,183 -55,197 -55,370
Impairment on equity securities- - - -220
Other, net-17 -31 -10 -4
Interest income7,248 7,538 7,537 7,681
Interest expense8,243 8,665 9,026 9,282
Gain (loss) on marketable equity securities, net4,967 941 9,254 -12,027
Asset impairment charges1,858 4,865 - -
Total other income (expense)2,097 -5,082 7,755 -13,412
Loss before income tax (benefit) expense and noncontrolling interest-31,075 -48,265 - -
Income tax (benefit) expense-250 367 - -
Net loss including noncontrolling interest-30,825 -48,632 -47,442 -68,782
Net loss attributable to noncontrolling interest- -214 -1,154 -1,445
Net loss attributable to xencor, inc-30,825 -48,418 -46,288 -67,337
Net loss per share attributable to xencor, inc. - basic (in dollars per share)-0.41 -0.66 -0.72 -1.09
Net loss per share attributable to xencor, inc. - diluted (in dollars per share)-0.41 -0.66 -0.72 -1.09
Weighted-average shares used in calculating - basic (in shares)74,279,000 73,667,000 64,022,547 61,676,444
Weighted-average shares used in calculating - diluted (in shares)74,279,000 73,667,000 64,022,547 61,676,444
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Net lossattributable to xencor, inc-$30,825K (54.22%↑ Y/Y)Net loss includingnoncontrolling interest-$30,825K (55.18%↑ Y/Y)Income tax (benefit)expense-$250K Gain (loss) onmarketable equity...$4,967K (141.30%↑ Y/Y)Interest income$7,248K (-5.64%↓ Y/Y)Loss before incometax (benefit)...-$31,075K Total other income(expense)$2,097K (115.64%↑ Y/Y)AlexionPharmaceuticals Inc$16,825K Morpho Sys Incyte$26,774K Vir BiotechnologyInc.$9K Asset impairmentcharges$1,858K Interest expense$8,243K (-11.19%↓ Y/Y)Other, net-$17K (-325.00%↓ Y/Y)Operating loss-$33,172K (40.09%↑ Y/Y)Collaborations, milestones, androyalties$43,608K (82.41%↑ Y/Y)Total operatingexpenses$76,780K (-3.15%↓ Y/Y)General andadministrative$15,115K (-14.83%↓ Y/Y)Research and development$61,665K (0.22%↑ Y/Y)